ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 709944 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 709944; 2) Community: the network communities that were significantly associated with the response to NSC 709944; 3) Molecule: the relationships between components within communities and NSC 709944; 4) MDR: the compounds that were significantly associated with the NSC 709944.

NSC Compound Enrichment Correlation
NSC 100071 component of Halotex 0.00313644776247638 0.4668306
NSC 123461 Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) 0.00313644776247638 0.45900987
NSC 142475 Null 0.00313644776247638 0.33911189
NSC 176503 Fastigilin B 0.00313644776247638 0.62463369
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.00313644776247638 0.49236158
NSC 626878 Cyclopentanone, 2-[(dimethylamino)methyl]-5-pentylidene-, hydrochloride 0.00313644776247638 0.45610561
NSC 627581 Null 0.00313644776247638 0.58862395
NSC 639976 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)- phenyl]ethylidene]-5-[(4-morpholinyl)methyl]-, hydrochloride 0.00313644776247638 0.55792209
NSC 651922 Null 0.00313644776247638 0.36049101
NSC 659853 2-Methoxy-.beta.-estradiol 0.00313644776247638 0.43550734
Total:96  Current:10    [First] [Prev] [Next] [Last]